Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Grebely

Showing results (281-290 of 368) with videos related to

Pageof 37
Sort By:
The Lancet. Gastroenterology & Hepatology|February 24, 2025
Global, regional, and national estimates of hepatitis C virus (HCV) infection incidence among people who inject drugs and number of new annual HCV infections attributable to injecting drug use: a multi-stage analysisAdelina Artenie, Adam Trickey, Katharine J Looker, et al.
Canadian Liver Journal|July 28, 2023
Public reimbursement policies in Canada for direct-acting antiviral treatment of hepatitis C virus infection: A descriptive studyGaelen Snell, Alison D Marshall, Jennifer van Gennip, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|November 8, 2013
The Second Canadian Symposium on hepatitis C virus: a call to actionJason Grebely, Marc Bilodeau, Jordan J Feld, et al.
Open Forum Infectious Diseases|November 16, 2018
Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in Patients With Chronic Hepatitis C Virus Genotype 1 Infection Receiving Opioid Substitution Therapy: A Post Hoc Analysis of 12 Clinical TrialsJason Grebely, Massimo Puoti, Heiner Wedemeyer, et al.
The Journal of Infectious Diseases|February 12, 2022
Diagnostic Accuracy of Assays Using Point-of-Care Testing or Dried Blood Spot Samples for the Determination of Hepatitis C Virus RNA: A Systematic ReviewBeth Catlett, Behzad Hajarizadeh, Evan Cunningham, et al.
Canadian Journal of Gastroenterology & Hepatology|October 15, 2014
The 3rd Canadian Symposium on Hepatitis C Virus: expanding care in the interferon-free eraSonya A MacParland, Marc Bilodeau, Jason Grebely, et al.
International Journal of Epidemiology|December 4, 2012
Cohort profile: the international collaboration of incident HIV and hepatitis C in injecting cohorts (InC3) studyJason Grebely, Meghan D Morris, Thomas M Rice, et al.
Gastroenterology|May 28, 2014
A summary of the 20th International Symposium on Hepatitis C Virus and Related VirusesMichael R Beard, Rose Ffrench, Eric J Gowans, et al.
The International Journal on Drug Policy|November 4, 2021
Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependenceMichael Farrell, Jeyran Shahbazi, Marianne Byrne, et al.
Eclinicalmedicine|April 18, 2024
Sex and gender differences in hepatitis C virus risk, prevention, and cascade of care in people who inject drugs: systematic review and meta-analysisAnna Levinsson, Camille Zolopa, Farzaneh Vakili, et al.
Pageof 37

Showing results (281-290 of 368) with videos related to

Sort By:
Pageof 37
The Lancet. Gastroenterology & Hepatology|February 24, 2025
Global, regional, and national estimates of hepatitis C virus (HCV) infection incidence among people who inject drugs and number of new annual HCV infections attributable to injecting drug use: a multi-stage analysisAdelina Artenie, Adam Trickey, Katharine J Looker, et al.
Canadian Liver Journal|July 28, 2023
Public reimbursement policies in Canada for direct-acting antiviral treatment of hepatitis C virus infection: A descriptive studyGaelen Snell, Alison D Marshall, Jennifer van Gennip, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|November 8, 2013
The Second Canadian Symposium on hepatitis C virus: a call to actionJason Grebely, Marc Bilodeau, Jordan J Feld, et al.
Open Forum Infectious Diseases|November 16, 2018
Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in Patients With Chronic Hepatitis C Virus Genotype 1 Infection Receiving Opioid Substitution Therapy: A Post Hoc Analysis of 12 Clinical TrialsJason Grebely, Massimo Puoti, Heiner Wedemeyer, et al.
The Journal of Infectious Diseases|February 12, 2022
Diagnostic Accuracy of Assays Using Point-of-Care Testing or Dried Blood Spot Samples for the Determination of Hepatitis C Virus RNA: A Systematic ReviewBeth Catlett, Behzad Hajarizadeh, Evan Cunningham, et al.
Canadian Journal of Gastroenterology & Hepatology|October 15, 2014
The 3rd Canadian Symposium on Hepatitis C Virus: expanding care in the interferon-free eraSonya A MacParland, Marc Bilodeau, Jason Grebely, et al.
International Journal of Epidemiology|December 4, 2012
Cohort profile: the international collaboration of incident HIV and hepatitis C in injecting cohorts (InC3) studyJason Grebely, Meghan D Morris, Thomas M Rice, et al.
Gastroenterology|May 28, 2014
A summary of the 20th International Symposium on Hepatitis C Virus and Related VirusesMichael R Beard, Rose Ffrench, Eric J Gowans, et al.
The International Journal on Drug Policy|November 4, 2021
Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependenceMichael Farrell, Jeyran Shahbazi, Marianne Byrne, et al.
Eclinicalmedicine|April 18, 2024
Sex and gender differences in hepatitis C virus risk, prevention, and cascade of care in people who inject drugs: systematic review and meta-analysisAnna Levinsson, Camille Zolopa, Farzaneh Vakili, et al.
Pageof 37